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ABSTRACT 
A woman requires more nutrition during pregnancy, which is a 
physiological condition. When compared to non-pregnant women, a 
pregnant woman needs 2-3 times the amount of iron than usual. Pandu 
means pallor of body which can be correlated with 'Anemia' of modern 
science. Many references in Ayurvedic classics denote that Garbhini 
Pandu is available.  
Design: 30 patients of Garbhini Pandu were selected from OPD and IPD 
of Prasuti Tantra and Stree Roga department from Dr.BRKR GAMC, 
Hyderabad and were administered 15ml of Drakshaghrita twice daily 
(morning and evening) on empty stomach orally along with Anupana of 
Sukoshnadugdha consecutively for 90 days.  
Results: Statistically highly significant results were seen in Pallor, 
Glossitis, Bhrama, Hrudrava, Hb% and edema of the lower extremity with 
p< 0.001.  
Conclusions: The study showed that Draksha Gritha is effective in the 
management of Garbhini Pandu. 
 
INTRODUCTION 
Woman indeed is the source of human 
progeny. When protected, she protects the progeny. 
A woman undoubtedly is the ultimate source of 
human progeny. The continuity and health of the 
society as well as universe depends upon her. 
Hence prime importance has been laid upon her 
health care in Indian Shaastras due to her role in 
giving birth to Shreyasipraja, a progeny which is 
physically, mentally, socially as well as healthy. In 
Ayurveda great importance has been given to 
Garbhini paricharya including Pathyaapathya to 
protect the growing foetus and mother, to ensure 
optimum nourishment to both. Pregnancy is a 
demanding stage. The foetus is completely 
dependent on its mother for nutrition, which is 
necessary for its growth and development. As per 
Ayurvedic classics, this condition occurs due to 
improper Rasa Dhatu function in mother and 
continuous increasing fetal demands and is 
considered as a Rasa Pradoshajavikara[1] Acharya 
Charaka in Sharirasthana has explained about Bala 
varna hani of Garbhini in 6th month of pregnancy. 
This can be considered as reference for Garbhini 
pandu. Shodhana is the line of treatment in 
Panduroga.  
Acharya Kashyapa has described Pandu as a 
symptom of Garbhini in the description of Rakta 
Gulma.[2] Acharya Harita has opined Vivarnatva as 
one of the eight complications of Garbha.[3] In the 
management, as Shodhana is contraindicated 
during pregnancy, appropriate Shamana treatment 
has to be adopted. “Draksha Ghrita” mentioned in 
Charaka Samhita, has been taken for study. Draksha 
has got Vatapittashamaka, Rakthaprasadana, 
Garbhasthapaka, Jeevaniya, Balya and Brihmana 
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properties. Ghrita has also Vatapittahara and Varna 
prasadana properties. 
It also shows Samskarasyanuvartanath 
property. Hence Ghritha and Draksha both are 
suitable drugs for Garbhinipandu with specific 
reference to Anaemia in Pregnancy. With the above 
ideology and as there were no studies on 
Drakshaghrita administration in the Garbhinipandu, 
the present study was taken up to evaluate the 
same. 
METHODOLOGY 
Subjects: Thirty patients of Garbhini Pandu were 
selected and included in the study based on the 
eligibility criteria irrespective of diet, occupation & 
religion from O.P.D., I.P.D., of Prasuti Tantra and 
Stree Roga & cases referred by other departments 
of Dr B.R.K.R. Govt. Ayurvedic Medical College & 
Hospital, Hyderabad. 
Patients in the age group of 18-32yrs, both 
primi and multigravida with Hb% ranging between 
7 to 10gm% and women in 2nd and 3rd trimester of 
pregnancy were included for the study irrespective 
of religion. Patients with Hb% below 7gm% and 
with anemia due to other pathologies like bleeding 
piles, A.P.H, nephritis and all other Raktha 
pradoshajavikaras were excluded from the study. 
Patients with other obstetric complications like pre-
eclampsia or eclampsia, gestational diabetes, 
systemic diseases such as diabetes, hypertension, 
thalesimia, sickle cell anemia, pernicious anemia, 
rheumatoid arthritis and other chronic diseases 
were also excluded. 
Study Design: This was an open clinical trial and an 
observational study. Informed consent was taken 
from all the patients before including them in the 
trial with 30 patients selected randomly. A case 
proforma was designed to collect all the important 
data related to patients of Garbhinipandu, treatment 
adopted and other information. Standard scorings 
for the subjective as well as objective parameters 
were done before and after treatment. Ethical 
clearance was obtained from the institutional 
ethical committee.  
Assessment Criteria 
Subjective Parameters: Pallor, Glossitis, Hrudrava 
/Hrudayaspandana, Bhrama. 
Objective Parameters: Hb%, Odema. 
Diagnostic Criteria: Hb%, RBS, HIV I & II, HbsAg, 
VDRL, CUE, USG - Obstetrics. 
Assessments were done before and after treatment. 
Follow up: Was done one month after medication 
was given and patients were advised follow up for 3 
consecutive cycles. 
Gradation of Parameters 
Table 1 Gradation of Subjective parameters 
Subjective Parameters  
Grading of Pallor  
No pallor 0 
Pallor of conjunctiva 1 
Pallor of conjunctiva, mucous membrane, nail 2 
Pallor of conjunctiva, skin, mucous membrane, nail 3 
Grading of Glossitis  
Absent 0 
Difficulty during chewing, swallowing and speaking 1 
Above symptoms + smooth, sore and tender tongue 2 
Above symptoms + swelling of tongue 3 
Grading of Hridayaspandana/ Hrudrava (Palpitations)  
No Palpitations 0 
Palpitations not affecting daily activities. 1 
Palpitations affecting daily activities. 2 
Palpitations at rest. 3 
Bhrama (Giddiness)  
No Giddiness 0 
Occasionally present 1 
Giddiness occurs on change in posture 2 
Constant giddiness 3 
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Table 2 Gradation of Objective parameters 
Objective Parameters 
Grading of Hb gm%   
 0 9- 10gms%/dl  With raise in above 3gms%/dl 
 1 8.6-8.9gms%/dl  With raise in 1-2.9gms%/dl 
 2 8-8.5gms%/dl  With raise in 0.5-0.9gms%/dl 
 3 7-7.9gms%/dl  No raise in Hb% 
Grading of Edema in 
Lower Extremity 
  
 No pitting 0 
 Mild pitting. 2mm depression that 
disappears rapidly 
1 
 Moderate pitting. 4 mm depression 
that disappears in 10-15 secs. 
2 
 Severe pitting. 6mm depression 
that may last more than 1 min. 
3 
Table 3 Criteria for Overall Result Assessment 
Effect of Percentage 
Excellent Improvement 76%- 100% 
Good Improvement 51%-75% 
Moderate Improved 26%-50% 
Mild Improvement <25% 
Intervention 
The present clinical study was intended to 
assess the management of Garbinipandu by the oral 
use of Drakshagritha. All the 30 patients were 
administered with 15ml of Drakshaghrita twice 
daily (Morning and evening) on empty stomach 
orally along with Anupana (after drink) of 
Sukoshnadugdha for 90 days continuously. The 
treatment was planned for 90 days with three 
follow up on 30th, 60th and 90th day.  
Draksha Gritha 
Materials: Draksha, Murchitha Gritha 
Preparation 
Ghrita Murchana[4] 
One Prastha (800ml) of ghee was taken and 
heated on mild fire till the complete disappearance 
of moisture content. Then the paste made of 
Haritaki, Amalaki, Vibhitaki, Nagara, Musta and 
Haridra was taken in equal quantity, all mixed 
together and made into a paste form by 
Matulungaswarasa. This paste was then added with 
ghee slowly and heated till the removal of moisture 
content. For this, Drakshakalka was added after 
cooling the ghee and then again it was heated for 
some time and filtered. 
Preparation of Draksha Kalka 
Fresh Draksha fruits were collected and 
seeds were removed from the fruits. Then they 
were grinded nicely and the Kalka was prepared 
and kept ready to add in the preparation of 
Snehakalka. 
Preparation of Draksha Ghrita 
Draksha Ghrita was prepared according to 
Snehakalpana vidhi,[5] where one part of the 
Drakshakalka, 4 parts of Go-ghrita and 16 parts of 
water were added together, boiled and reduced to 
the quantity of ghee. This was done slowly under a 
mild flame till the Sneha siddilakshanas were 
attained to obtain the Madhyamapaka for oral 
administration. 
Administration of Draksha Ghrita 
15ml of Drakshaghrita was given twice daily 
(morning and evening) on empty stomach orally 
along with Anupana of Sukoshnadugdha for 
administered 90 days continuously. 
RESULTS 
Thirty patients with only second trimester 
were subjected for clinical trial where, 15ml of 
“Draksha Ghrita” with Anupana as Sukoshnaksheera 
was administered orally morning and evening on 
empty stomach for 90 days daily. Assessments were 
carried out before and after treatment and results 
were assessed monthly once by both subjective and 
objective parameters. 
More patients were observed in the age 
group of 23-27 yrs with 14 patients. Among 30 
patients, 17 were housewives and 13 were 
employees. The increased incidence of Pandu 
among housewives was may be due to the poor 
quality of life style, food habits and alteration of 
food consuming times in housewives and 
negligence of proper diet by women due to work 
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and stress at their home. Regarding the socio-
economic background, 33.33% were from middle 
class, 43.33% were low class and 23.33% were 
from high class. Low class people are more prone to 
this, because of malnutrition, maximum numbers of 
patients (63.33%) were consuming vegetarian diet, 
Heme and nonheme are the two sources of dietary 
iron. Nonheme iron is major source in plant origin 
and its absorption is limited due to the presence of 
fiber, phytate and phosphate and polyphenol 
present. Heme iron present in meat, fish and 
poultry is better absorbed and is not influenced by 
dietary factors. Thus vegetarians are more prone to 
suffer from iron deficiency. Among 30 patients, 50% 
were primipara, 33.33% were of second gravida 
and 16.66% were of multipara. In this study, 
primiparas are affected more with Anaemia. 
36.66% were of 4th month gestational age, 30% 
were of 5th month gestational age and 33.33% were 
of 6th month gestational age. In this study, on an 
average anemia is affected to the patients of 5th 
month gestational age, as said it affects mainly 
during the second trimester. 
Regarding Hb% range, among 30 patients, 
26.66% were between 7-8 gms Hb%, 36.66% were 
between 8-9gms Hb% and 36.66% were between 9-
10gms%, 56.66% of patients belonged to Hindu 
community due to the dominant population in the 
study area. 
Table 4: Demographic Data 
Age Group 18 – 22 Yrs 11  
 23 – 27 Yrs 14  
 28 – 32 Yrs 05  
Occupation House Wife 13  
 Employee  15  
 Others  02  
Socio-Economic status Low  13 
 Middle  10  
 Upper  07  
Dietary Habit Vegetarian 11 
 Non-Vegetarian 19 
Gravida Primary  15  
 Secondary  10  
 Multi  05  
IInd Trimester 4th Month  11  
 5th Month 09  
 6th Month  10  
Haemoglobin (Hb %) 7 – 8 gms %  08  
 8 – 9 gms %  11  
 9 – 10 gms %  11  
Effect of Treatment 
Patients between age group of 18 to 22 
years got more improvement than other age groups 
because of young and energetic age with good 
metabolism. Out of 11, excellent result was 
observed in 1 patient, good results were observed 
in 9 patients and moderate results were observed in 
1 patient. With occupation, 15 patients who were 
employees got more improvement than housewives 
because of knowledge they had regarding the 
nutritional value of the food and concern on their 
health. So, they took medicine properly after the 
counseling. Out of 15, excellent results were 
observed in 2 patients, good results were observed 
in 11 patients and moderate results were observed 
in 2 patients.  
With respect to socio-economic background, 
7 Patients who belonged to upper socio-economic 
status got more improvement than low and 
middleclass patients due to the extra nutritious diet 
they consume along with the clinical study drug. 
Out of 7, excellent results were observed in 2 
patients and good results were observed in 5 
patients. 19 patients who were consuming non-
vegetarian diet had more improvement than 
vegetarian patients as heme iron present in meat, 
fish and poultry and is better absorbed whereas 
nonheme iron which is a source of plant origin has 
got limited absorption due to the presence of fiber, 
phytate and phosphate and polyphenol. Out of 19, 
excellent results were observed in 2 patients, good 
results were observed in 12 patients, and moderate 
results were observed in 4 patients with mild result 
in 1 patient.  
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In 10 patients who were in second gravida 
had seen more improvement than primigravida and 
multi gravida patients. Out of 10, excellent results 
were observed in 4 patients, good results were seen 
in 5 patients and moderate result in1 patient. 9 
Patients who were in their 5th month of gestational 
age were seen more improvement than 4th and 6th 
month gestational age patients. Out of 9, excellent 
results were observed in 2 patients, good results in 
6 patients and moderate in 1 patient. Among 27 
patients suffering from pallor, excellent results 
were observed in 25 patients and good results in 2 
patients. Before the treatment 8 patients were 
under 7-8gms of Hb% and the average of Hb% for 
these 8 patients before treatment was 7.45gms%, 
whereas after the treatment the average Hb% had 
increased to 10.46%. In 11 patients, before the 
treatment, the Hb% was 8-9gms% and the average 
of Hb% was 8.35gms%, but after the treatment the 
average Hb% had increased to 10.70%. In 11 
patients with 9-10gms of Hb%, average was 
9.30gms% and after treatment average Hb% had 
gone upto 11.45%.  
In both the subjective and objective 
parameters, overall results were interpreted as 
13.33% of excellent improvement, 63.33% of good 
improvement, 20% of moderate improvement and 
3.33% of mild improvement. Among 19 patients 
suffering from edema, excellent results were 
observed in 11 patients and good results were seen 
in 8 patients.  
Subjective Parameters 
Pallor 
The initial mean score of pallor was 1.366 
before the treatment and reduced to 0.066 after the 
treatment with statistical significance (p<0.001). 
Glossitis  
The initial mean score of pallor was 0.833 
before the treatment and reduced to 0.266 after the 
treatment with statistical significance (p<0.001). 
Hrdrava/Hrudayaspandana 
The initial mean score of pallor was 0.733 
before the treatment and reduced to 0 after the 
treatment with statistical significance (p<0.001). 
Bhrama 
The initial mean score of pallor was 1.1 
before the treatment and reduced to 0.1 after the 
treatment with statistical significance (p<0.001). 
Objective Parameters 
Hb% 
The initial mean score of pallor was 8.473 
before the treatment and reduced to 10.91 after the 
treatment with statistical significance (p<0.001). 
Odema 
The initial mean score of pallor was 1.333 
before the treatment and reduced to 0.2 after the 
treatment with statistical significance (p<0.001). 
With the above data, 70.34% results were 
observed in signs and symptoms with excellent 
results, 19.49% of good results and 10.16% of 
moderate results.  
Table 5 Showing Signs and Symptoms 
Signs and 
Symptoms 
Before 
Treatment 
After Treatment 
Excellent Result Good Result Moderate result 
Pallor (27) 90 % (25) 92.59 % (2) 7.40 % ---- 
Glossitis (19) 63.3 % (11) 57.89 % (8) 42.10 % ---- 
Hrudrava (16) 53.3 % (16) 100 % --- ---- 
Bhrama (22) 73.3 % (19) 86.36% (3) 13.63% ----- 
Odema (27) 90 % (21) 77.77 % (6) 22.22 % ---- 
Table 6 Effect of Study 
S.No  Symptoms   Mean  SD   S.E   Df  T- value  P-value  S  
  B.T  A.T  B.T  A.T  B.T  A.T      
1. Pallor  1.366  0.0666  0.8087  0.2537  0.14  0.04  29  8.4009  <0.001  E.S  
2. Glossits 0.833  0.2666  0.7466  0.4497  0.14  0.08  29  3.5608  <0.001  S  
3. Hrudrava 0.733  0  0.7849  0  0.14  0  29  5.1173  <0.001  E.S  
4. Bhrama 1.1 0.1 0.8030 0.3051 0.14 0.05 29 6.3761 <0.001  E.S  
5.  Hb%  8.473  10.91  0.7851  1.030  0.14  0.19  29  10.836  <0.001  E.S  
6. Odema 1.333  0.2  0.7581  0.4068  0.14  0.08  29  7.215  <0.001  E.S  
 Total grading score  16.70  12.008  6.4655  3.4214  1.16  0.56  29  7.5209  <0.001  E.S  
Df = degrees of freedom, E.S = Extremely significant, S = Significant 
 
 
 
DISCUSSION  
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The speciality of giving birth to a child made 
a woman noble for the creative aspect of life. This is 
the key chain of continuation of progeny. Pregnancy 
is a unique process and experience in women’s life 
as it creates a new budding life. All her needs must 
be fulfilled as one life participates in the creation of 
another and care must be taken to bring this new 
life into the world. Many physiological changes are 
taking place in women during her reproductive life. 
As a consequence, to these changes certain 
conditions manifest among which Garbhini Pandu is 
one. Acharyas have significantly explained 
Garbhinimasanumasika paricharya[6] to prevent the 
complications of pregnant woman and to have full 
term healthy child. Charaka has specified the 
general line of treatment for Garbhinivyapathas. 
In Ayurveda, references regarding Garbhini 
Pandu are available in scanty. Kashyapa has 
mentioned Panduta in Garbhini emphasizing that 
any disease can manifest during pregnancy and the 
general line of treatment of that particular disease 
can be adopted. Though Pandu as a disease entity is 
mentioned in Ayurvedic texts “Garbhini Pandu” is 
not mentioned in any of Ayurvedic classics. There 
are only passing references like Garbhini Vivarnata, 
Garbhini Balavarnahani and Asita Sati. So, the Pandu 
Roga which is elaborately explained in classics can 
be taken into consideration for Garbhini also. 
In Classics always usage of Teekshna 
aushadha are restricted for pregnant women. 
Therefore it is advised to use mild potency 
medicines[7] even in severe conditions. In modern 
science, iron supplementation is needed for all 
pregnant women from 16th to 20th weeks onwards. 
It correlates completely with our classical opinion 
like. [8] 
Different Nidanas are mentioned which 
cause anaemia. Nidanas like Aahara containing 
excess of Kshara, Amla, Lavana rasa Atisevana plays 
very important role in the pathogenesis of Pandu 
Roga.  
The present study was aimed at finding a 
safe and effective management in Pandu by 
administration of “Draksha Ghrita” which contains 
Draksha and Go-ghrita with Anupana as 
Sukoshnaksheera.  
Mode of Action  
The drug Draksha is Madhura in Rasa and 
has Madhuravipaka, Sheetaveerya, Snigdha, Guru 
and Mridugunas and it is Vatapittashamaka. The 
disease Pandu is mainly Pittaprakopajanyavyadhi 
and acts as Pittasamaka. Even while mentioning the 
Karmas of Draksha, Rakthapittashamaaka karma is 
also mentioned. Thus it is clearly understood that 
this drug might act on the Dushita pitta and is 
effectively capable of bringing back Pitta to its 
normalcy. Draksha has also got the Karmas like 
Rakthaprasadana, Garbhasthapana, Jeevaniya, and 
Balya. Thus by the Karmas of Draksha mentioned in 
the classics, it can be inferred that the drug Draksha 
might cure anemia and an effective drug that can be 
used during pregnancy, which can even prevent 
uneventful situations during ante-natal period. 
Ghrita alleviates Pitta and Vata, is beneficial 
for Rasa dhatu and thereby maintains proper Dhatu 
parinama karma. It has Sheetavirya, Mrudu and 
Varna prasadana properties. Ghrita which has 
Rasayana property when administered promotes 
longevity and protects body from various diseases. 
It is also Ruchikara. Ghrita has got mainly 
Samaskarasyanuvarthana[9] property. It means, 
when treated or impregnated with other drugs, the 
Ghrita has a specific property of accepting the 
attributes of these drugs without losing its own 
characters. In other words, Ghrita has the capacity 
to transform itself so as to imbibe all the qualities of 
the substances added to it. This assimilating 
property is not so prominent in other Snehadravyas 
(Taila, Vasa, Majja). It is particularly significant that 
ghee doesn’t give up its own properties even if it is 
mixed up with other substances possessing other 
properties. Ghrita has got a good Pachaka property, 
which helps in proper digestion and there by 
clearing all the Aama from the body, by this body 
and the Srothases becomes clean. Thus, Pachakagni 
is maintained at Saamyavastha, no Dusti in seen in 
the Rasavahasrotas, by which Dhatwagni is 
maintained well and Dathuparinamakrama occur 
accurately. Ultimately Rakthadhathu is also formed 
well. Ghrita possesses Varnaprasadana and 
Twachya properties. Ghrita while alleviating the 
Pitta and maintaining its normalcy, it attributes 
Ranjaka pitta to work well during the 
transformation of Rasa dhatu to Rakthadhathu. 
There by no Pandu varna is formed. 
Draksha has Brimhana property which helps 
in proper Rasa dhatu formation, where in the 
proper Dhatu parinama krama takes place from 
Rasadhathu to Rakthadhathu. Therefore the proper 
functioning of Dhathuparinamakarma ensures 
Rakthadhathu formation. Draksha has also 
Kaphanissaraka property which means it takes of 
excess Kapha out from the body and makes the 
Srotases clean and clear thus absorption is 
increased. The Roghaghnata of the drug Draksha 
are Bhrama, Vibandha, Pandu, Hriddourbalya, 
Garbhsayadourbalaya, Samanyadourbalya, Krishata, 
Sosha, Twakroga. As the direct reference of 
Panduroga is given in the context of Roghagnata of 
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Draksha and as it is a Mridudravya can bead 
ministered in Garbhinipandu. 
The chemical composition[10] of the drug 
Draksha fruit contains dehydro ascorbic acidie 
oxidized form of ascorbic acid, which helps in the 
absorbtion of the available iron.[11] Arginine[12] 
which is found in the pulp of the fruit is a semi-
essential amino acid. It is involved in many 
metabolic processes and important in the treatment 
of heart diseases and high blood pressure. In 1998, 
the Nobel Prize for Medicine was given for arginine 
improves the circulation and oxygen supply of the 
coronary and peripheral vessels through the release 
of nitric oxide. When arginine is consumed, the 
nitric oxide level in the blood increases. Nitric oxide 
relaxes the walls of the blood vessels and thereby 
improves the circulation in the whole body. Thus by 
the above explanation, drug can even prevent P.I.H. 
In view of the above physiology of arginine, a 
marked result is seen in the symptom Hridrava.  
Arginine supports the production of 
collagen and is therefore an important contributor 
to bone growth. In turn, arginine supports the 
growth of the osteoblasts which form the bone 
mass. Thus it favors the skeletal growth of the fetus 
there by preventing I.UG.R. Alanine which is a 
nonessential amino acid is found in the fruit. Amino 
acids are the building blocks of protein which helps 
in building strong and healthy muscles. Alanine[13] 
has been shown to help protect cells from being 
damaged during intense aerobic activity, when the 
body catabolize muscle protein to help produce 
energy. Thus one can say by the action of alanine 
the symptom Dourbalya is reduced. Alanine 
processes vitamin-B especially vitamin B5 
(pantothenic acid) and vitamin B6 (pyridoxine).  
While mentioning the pharmacological 
activities of Draksha, angiotensin converting 
enzyme (ACE)[14] activity has been mentioned. 
Renin-Angiotensin (RAS) plays its role in HTN and 
atherosclerosis. RAS helps in fluid homeostasis 
regulation. Angiotensin II stimulates the 
proliferation of CD34+cord blood cells in vitro. RAS 
helps in regulating hematopoietic progenitor 
differentiation and self-renewal. Ang-(1–7), Ang II 
has utility and clinical significance in bone marrow 
transplantation. AGTRI 1 and AGTRI 2 acts as 
mediator in haematopoietic system. Ang II receptor 
antagonists and ACE inhibitors are commonly used 
for treatment of cardiovascular diseases, post-
transplantation erythrocytosis, or polycythemia 
vera. RAS components and their inhibitors maintain 
the balance in the hematopoietic and cardiovascular 
systems.  
Oleanolic acid is a triterpenoid which exists 
in nature as a free acid or as an aglycone of 
triterpenoid saponins and it is often ubiquitously 
found with its isomer, usolic acid[15] The 
Oleanolicacid is a phytochemical Triterpenoid found 
in fruit of Draksha.[16] It has got Anti inflammatory, 
Antihypertensive properties.[17,18] An oleanolic acid 
derivative, methyl 3-octanoyloxyiminoolean-12-en-
28-oate, also showed anti-inflammatory activity 
demonstrated by its anti-oedemic effects in rats 
with carrageenan-induced skin inflammation.[19] 
The use of oleanolic acid significantly 
prevented an increase in the systolic blood pressure 
and cardiac lipid peroxidation level. However, there 
was no significant effect on changes in body and 
thymus weights which were previously caused by 
the glucocorticoid treatment.[20,21] Thus this 
chemical constituent acts on the symptom oedema. 
As there are many amino acids like proline, alanine 
and arginine in the pulp of the fruit it helps in the 
contribution of proteins which is one of the main 
constituent present in the amniotic fluid. Thus it 
helps in maintenance of the normal level of 
amniotic fluid thereby preventing oligohydromnios.  
CONCLUSIONS 
Garbhinipandu is the most common 
haematological disorder. So, considering the 
necessity to have a drug which is beneficial in 
Panduroga, safe and cost effective Drakshaghrita 
was selected for study. This study has showed 
statistically significant results in both subjective 
and objective parameters. Follow up has also 
showed the improvement in haemoglobin 
concentration throughout the pregnancy. 
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